Search Ontology:
ChEBI
dihydroouabain
- Term ID
- CHEBI:131146
- Synonyms
-
- (1beta,3beta,5beta,11alpha,20xi)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycardanolide
- (20xi)-3beta-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1beta,5,11alpha,14,19-pentahydroxy-5beta-cardanolide
- 3beta-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1beta,5,11alpha,14,19-pentahydroxy-5beta,20xi-cardanolide
- dihydro-g-strophanthin
- dihydroouabain
- Definition
- A cardenolide glycoside that is ouabain in which the double bond in the lactone ring has been reduced to a single bond. It is a cardiac glycoside and a derivative of ouabain which is used as a sodium pump antagonist and exhibits ionotropic effects.
- References
-
- cas:1183-35-3
- hmdb:HMDB0251322
- lincs.smallmolecule:LSM-42697
- pubmed:10564763
- pubmed:1178065
- pubmed:1192564
- pubmed:1239002
- pubmed:12399817
- pubmed:12954807
- pubmed:1311424
- pubmed:19778013
- pubmed:2442703
- pubmed:2541941
- pubmed:2851817
- pubmed:29981919
- pubmed:32311597
- pubmed:6290892
- pubmed:6326779
- pubmed:6571229
- pubmed:677969
- pubmed:7498266
- pubmed:7854342
- pubmed:8387052
- pubmed:8411196
- pubmed:978481
- reaxys:71786
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from dihydroouabain
Phenotype where environments contain dihydroouabain
Phenotype modified by environments containing dihydroouabain
Phenotype affecting dihydroouabain
Human Disease Model